GB201110095D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB201110095D0
GB201110095D0 GBGB1110095.5A GB201110095A GB201110095D0 GB 201110095 D0 GB201110095 D0 GB 201110095D0 GB 201110095 A GB201110095 A GB 201110095A GB 201110095 D0 GB201110095 D0 GB 201110095D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1110095.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DuPont Nutrition Biosciences ApS
Danisco US Inc
Original Assignee
Danisco AS
Danisco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco AS, Danisco US Inc filed Critical Danisco AS
Priority to GBGB1110095.5A priority Critical patent/GB201110095D0/en
Publication of GB201110095D0 publication Critical patent/GB201110095D0/en
Priority to CN201280028506.2A priority patent/CN104168905B/zh
Priority to US14/124,959 priority patent/US20140112897A1/en
Priority to EA201490004A priority patent/EA031426B1/ru
Priority to JP2014514154A priority patent/JP6153517B2/ja
Priority to ES12727910.7T priority patent/ES2583695T3/es
Priority to BR112013031659-4A priority patent/BR112013031659B1/pt
Priority to PCT/GB2012/051302 priority patent/WO2012168732A1/fr
Priority to EP12727910.7A priority patent/EP2717889B1/fr
Priority to US15/625,263 priority patent/US20180036353A1/en
Priority to US16/238,098 priority patent/US20190269741A1/en
Priority to US17/409,466 priority patent/US20210379126A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB1110095.5A 2011-06-10 2011-06-15 Method of treatment Ceased GB201110095D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1110095.5A GB201110095D0 (en) 2011-06-15 2011-06-15 Method of treatment
EP12727910.7A EP2717889B1 (fr) 2011-06-10 2012-06-08 Traitement d'une maladie des voies respiratoires à l'aide de bifidobacterium lactis bl-04
JP2014514154A JP6153517B2 (ja) 2011-06-10 2012-06-08 ビフィドバクテリウム・ラクティスｂｌ−０４による呼吸器疾患の治療
US14/124,959 US20140112897A1 (en) 2011-06-10 2012-06-08 Treatment of Respiratory Tract Illness with Bifidobacterium Lactis BL-04
EA201490004A EA031426B1 (ru) 2011-06-10 2012-06-08 ПРИМЕНЕНИЕ Bifidobacterium lactis BL-04 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ДЫХАТЕЛЬНЫХ ПУТЕЙ
CN201280028506.2A CN104168905B (zh) 2011-06-10 2012-06-08 使用乳双歧杆菌bl-04治疗呼吸道疾病
ES12727910.7T ES2583695T3 (es) 2011-06-10 2012-06-08 Tratamiento de enfermedad del tracto respiratorio con Bifidobacterium lactis BL-04
BR112013031659-4A BR112013031659B1 (pt) 2011-06-10 2012-06-08 Uso de uma composição
PCT/GB2012/051302 WO2012168732A1 (fr) 2011-06-10 2012-06-08 Traitement d'une maladie des voies respiratoires à l'aide de bifidobacterium lactis bl-04
US15/625,263 US20180036353A1 (en) 2011-06-10 2017-06-16 Treatment of respiratory tract illness with bifidobacterium lactis bl-04
US16/238,098 US20190269741A1 (en) 2011-06-10 2019-01-02 Method of Treatment
US17/409,466 US20210379126A1 (en) 2011-06-10 2021-08-23 Method of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1110095.5A GB201110095D0 (en) 2011-06-15 2011-06-15 Method of treatment

Publications (1)

Publication Number Publication Date
GB201110095D0 true GB201110095D0 (en) 2011-07-27

Family

ID=44357821

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1110095.5A Ceased GB201110095D0 (en) 2011-06-10 2011-06-15 Method of treatment

Country Status (9)

Country Link
US (4) US20140112897A1 (fr)
EP (1) EP2717889B1 (fr)
JP (1) JP6153517B2 (fr)
CN (1) CN104168905B (fr)
BR (1) BR112013031659B1 (fr)
EA (1) EA031426B1 (fr)
ES (1) ES2583695T3 (fr)
GB (1) GB201110095D0 (fr)
WO (1) WO2012168732A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN103705654B (zh) * 2014-01-14 2018-05-22 邓小莉 一种用于治疗鼻炎的填充枕芯中药药丸及其制备方法
CN103720762B (zh) * 2014-01-14 2018-05-22 邓小莉 治疗鼻炎蒸熏剂及其制备方法
EP3065748B1 (fr) 2014-12-23 2017-11-22 4D Pharma Research Limited Une lignée de bacteroides thetaiotaomicron et son utilisation pour la réduction des inflammations
HUE037476T2 (hu) 2014-12-23 2018-08-28 4D Pharma Res Ltd Pirin polipeptid és immunmodulálás
EP3250216B1 (fr) * 2015-01-27 2023-11-08 DuPont Nutrition Biosciences ApS Composition immunomodulatrice comprenant des bifidobactéries
EP3307288B1 (fr) 2015-06-15 2019-07-24 4D Pharma Research Limited Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3240554T3 (pl) 2015-06-15 2020-02-28 4D Pharma Research Limited Blautia stercosis i wexlerae do stosowania w leczeniu chorób zapalnych i autoimmunologicznych
RS63089B1 (sr) 2015-06-15 2022-04-29 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN106256352A (zh) * 2015-08-19 2016-12-28 徐琳 用于减少与pm2.5暴露相关的肺部和/或全身性炎症的组合物及其用途
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013B1 (fr) 2015-11-20 2018-07-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
PT3313423T (pt) 2016-03-04 2019-07-10 4D Pharma Plc Composições que compreendem a estirpe blautia bacteriana para tratar a hipersensibilidade visceral
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3577213B1 (fr) * 2017-01-31 2024-06-05 Kansas State University Research Foundation Cellules microbiennes, leurs procédés de production, et leurs utilisations
PT3630136T (pt) 2017-05-22 2021-06-11 4D Pharma Res Ltd Composições que compreendem estirpes bacterianas
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MD3638271T2 (ro) 2017-06-14 2021-03-31 4D Pharma Res Ltd Compoziții cuprizând tulpini bacteriene
HRP20220747T1 (hr) 2017-06-14 2022-10-14 4D Pharma Research Limited Pripravci koji sadrže bakterijske sojeve
CA3079562A1 (fr) 2017-10-20 2019-04-25 Ms Biotech, Inc. Procedes de production de matieres vegetales ensilees a l'aide de megasphaera elsdenii
US11911420B2 (en) 2018-01-31 2024-02-27 Nutri Co., Ltd. Prophylactic and/or therapeutic agents for Streptococcus pneumoniae infection
CN110055185B (zh) * 2018-12-25 2020-12-29 江南大学 一株具有抗流感能力的短双歧杆菌及其应用
CN110893193B (zh) * 2019-06-27 2023-03-24 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99的新应用
CN111560335B (zh) * 2020-05-26 2022-09-23 北京科拓恒通生物技术股份有限公司 一株用于缓解哮喘的乳双歧杆菌及其应用
US11318174B2 (en) * 2020-07-09 2022-05-03 Dupont Nutrition Biosciences Aps Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
CN112402460A (zh) * 2020-12-14 2021-02-26 梁爱军 一种局部用益生菌液缩短感冒病程的方法
WO2023279093A1 (fr) * 2021-07-01 2023-01-05 Duke University Compositions et méthodes permettant de favoriser la santé respiratoire
CN114470010B (zh) * 2022-02-07 2024-02-27 北京华元生物技术研究院 乳双歧杆菌bl-11的新用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2008053444A2 (fr) * 2006-11-01 2008-05-08 The Procter & Gamble Company Méthodes visant à traiter un trouble respiratoire au moyen d'un traitement probiotique
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
JP5689601B2 (ja) * 2006-12-11 2015-03-25 デュポン ニュートリション バイオサイエンシーズ エーピーエス 組成物
EP2139502B1 (fr) * 2007-03-26 2014-06-18 DuPont Nutrition Biosciences ApS Lactobacillus et bifidobacterium contre l'allergie au bouleau
ITMI20072260A1 (it) * 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
CN101939411A (zh) * 2008-02-06 2011-01-05 宝洁公司 用于提高呼吸病症免疫应答的组合物、方法和试剂盒
CA2658440C (fr) * 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Composition laitiere comprenant des probiotiques et un agent antimicrobien

Also Published As

Publication number Publication date
ES2583695T3 (es) 2016-09-21
US20210379126A1 (en) 2021-12-09
US20180036353A1 (en) 2018-02-08
US20190269741A1 (en) 2019-09-05
CN104168905A (zh) 2014-11-26
EA201490004A1 (ru) 2014-09-30
US20140112897A1 (en) 2014-04-24
JP6153517B2 (ja) 2017-06-28
JP2014517003A (ja) 2014-07-17
EP2717889B1 (fr) 2016-04-20
EA031426B1 (ru) 2018-12-28
EP2717889A1 (fr) 2014-04-16
BR112013031659A2 (pt) 2016-12-06
WO2012168732A1 (fr) 2012-12-13
CN104168905B (zh) 2018-12-04
BR112013031659B1 (pt) 2021-08-31

Similar Documents

Publication Publication Date Title
EP2773754A4 (fr) Méthode de traitement
GB201110095D0 (en) Method of treatment
EP2723384A4 (fr) Traitement de protéinopathies
EP2717855A4 (fr) Procédés de traitement
PL3581199T3 (pl) Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej
GB201018147D0 (en) Method of treatment
IL230433A0 (en) Pain management methods
HK1199261A1 (en) Methods for treatment of diseases
ZA201403739B (en) Methods of treatment with deferiprone
GB201003920D0 (en) Method of treatment
EP2668260A4 (fr) Méthode de modification de bactéries
EP2672963A4 (fr) Méthodes de traitement d'un mélanome
EP2709466A4 (fr) Méthode de traitement du miel
EP2585103A4 (fr) Méthode de traitement
GB201105523D0 (en) Treatment method
GB201018149D0 (en) Method of treatment
EP2791324A4 (fr) Procédé de traitement
GB201020015D0 (en) Method of treatment
GB201111530D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201109266D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201221032D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)